NO2820418T3 - - Google Patents

Info

Publication number
NO2820418T3
NO2820418T3 NO13745268A NO13745268A NO2820418T3 NO 2820418 T3 NO2820418 T3 NO 2820418T3 NO 13745268 A NO13745268 A NO 13745268A NO 13745268 A NO13745268 A NO 13745268A NO 2820418 T3 NO2820418 T3 NO 2820418T3
Authority
NO
Norway
Application number
NO13745268A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2820418T3 publication Critical patent/NO2820418T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/60Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO13745268A 2011-08-17 2013-07-22 NO2820418T3 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161524508P 2011-08-17 2011-08-17

Publications (1)

Publication Number Publication Date
NO2820418T3 true NO2820418T3 (no) 2018-05-05

Family

ID=47715692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13745268A NO2820418T3 (no) 2011-08-17 2013-07-22

Country Status (15)

Country Link
US (1) US9290562B2 (no)
EP (1) EP2744831B1 (no)
JP (1) JP6073888B2 (no)
CN (2) CN103998470A (no)
AU (1) AU2012296588B2 (no)
BR (1) BR112014008680A2 (no)
CA (1) CA2849015C (no)
DK (1) DK2744831T3 (no)
ES (1) ES2659161T3 (no)
NO (1) NO2820418T3 (no)
PL (1) PL2744831T3 (no)
PT (1) PT2744831T (no)
SI (1) SI2744831T1 (no)
TR (1) TR201802686T4 (no)
WO (1) WO2013025846A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014180288A1 (zh) * 2013-05-06 2014-11-13 中国药科大学 具有抑制肿瘤微环境血管再生和激活适应性免疫应答双功能的融合蛋白及其基因和应用
JP2016522249A (ja) * 2013-06-20 2016-07-28 ノバルティス アーゲー 脈絡膜血管新生の治療におけるvegfアンタゴニストの使用
US11058750B2 (en) * 2015-12-03 2021-07-13 Mor Research Applications Ltd. Compositions and methods for treatment of ocular diseases
KR101818151B1 (ko) 2016-03-25 2018-01-16 한국과학기술원 트렌스페린을 포함하는 허혈성망막병증 예방 및 치료용 조성물
CN109053899B (zh) * 2017-12-22 2021-11-16 湖南远泰生物技术有限公司 一种含人转铁蛋白抗原表位序列的嵌合体抗原受体

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672683A (en) 1989-09-07 1997-09-30 Alkermes, Inc. Transferrin neuropharmaceutical agent fusion protein
US20050192242A1 (en) 1995-10-11 2005-09-01 Neal Zane C. Therapeutic fusion protein transgenes
IL140239A0 (en) * 1998-06-17 2002-02-10 Beth Israel Hospital Anti-angiogenic proteins and methods of use thereof
EP1244701A1 (en) 1999-12-23 2002-10-02 Human Genome Sciences, Inc. Transferrin polynucleotides, polypeptides, and antibodies
US8129504B2 (en) * 2001-08-30 2012-03-06 Biorexis Technology, Inc. Oral delivery of modified transferrin fusion proteins
BR0212256A (pt) 2001-08-30 2004-08-31 Biorexis Pharmaceutical Corp Proteìnas de fusão de transferrina modificadas
EP2277889B1 (en) 2001-12-21 2014-07-09 Human Genome Sciences, Inc. Fusion proteins of albumin and interferon beta
KR20040089608A (ko) * 2002-02-07 2004-10-21 델타 바이오테크놀로지 리미티드 Hiv 억제 단백질
EP1670428A4 (en) 2003-10-10 2008-03-12 Univ Southern California G-CSF TRANSFERRIN FUSION PROTEIN
AU2005219413A1 (en) * 2004-03-02 2005-09-15 Massachusetts Institute Of Technology Nanocell drug delivery system
WO2006044614A2 (en) 2004-10-14 2006-04-27 Sopherion Therapeutics, Inc. Anti-angiogenic peptides and methods of use thereof
WO2006049983A2 (en) 2004-10-27 2006-05-11 Biorexis Pharmaceutical Corporation Peptide yy modified transferrin fusion proteins
JP2008540342A (ja) * 2005-04-29 2008-11-20 リサーチ ディベロップメント ファウンデーション 眼の新生血管形成の血管標的化
ATE551067T1 (de) 2006-02-03 2012-04-15 Crc For Asthma And Airways Ltd Tumstatin zur behandlung von erkrankungen die mit der neumodellierung von atemwegsgewebe zusammenhängen
CN101070349B (zh) * 2007-05-22 2010-10-13 山西康宝生物制品股份有限公司 具有选择性杀伤肿瘤新生血管内皮细胞作用的融合蛋白与应用
CN101092452A (zh) * 2007-05-23 2007-12-26 哈尔滨医科大学 肿瘤抑素抗血管生成小分子多肽、融合蛋白及两者制备方法
US7943733B2 (en) * 2007-12-20 2011-05-17 University Of Southern California Spacers to increase the expression of recombinant fusion proteins
AU2012222833B2 (en) 2011-03-03 2017-03-16 Zymeworks Inc. Multivalent heteromultimer scaffold design and constructs

Also Published As

Publication number Publication date
TR201802686T4 (tr) 2018-03-21
BR112014008680A2 (pt) 2017-06-13
PL2744831T3 (pl) 2018-05-30
ES2659161T3 (es) 2018-03-14
US20140179612A1 (en) 2014-06-26
AU2012296588A1 (en) 2014-04-03
AU2012296588B2 (en) 2017-07-27
CA2849015C (en) 2017-08-08
WO2013025846A2 (en) 2013-02-21
JP6073888B2 (ja) 2017-02-01
WO2013025846A3 (en) 2013-05-02
EP2744831A2 (en) 2014-06-25
SI2744831T1 (en) 2018-04-30
DK2744831T3 (en) 2018-03-05
EP2744831A4 (en) 2015-03-11
CN103998470A (zh) 2014-08-20
EP2744831B1 (en) 2017-12-06
CN110105453A (zh) 2019-08-09
US9290562B2 (en) 2016-03-22
PT2744831T (pt) 2018-03-05
JP2014526890A (ja) 2014-10-09
CA2849015A1 (en) 2013-02-21

Similar Documents

Publication Publication Date Title
BR112013031251A2 (no)
BR112013027245A2 (no)
BR112013024383A2 (no)
BR112013026905A2 (no)
BR112013023185A2 (no)
BR112013026744A2 (no)
BR112013023927A2 (no)
BR112013027830A2 (no)
BR112013024365A2 (no)
BR112013028733A2 (no)
BR112013027121A2 (no)
BR112013027452A2 (no)
AP2016009466A0 (no)
BR112013031556A2 (no)
BR112013026790A2 (no)
BR112013024588A2 (no)
BR112013032380A2 (no)
BR112013032377A2 (no)
BR112013032368A2 (no)
BR112013026895A2 (no)
BR112013027761A2 (no)
BR112013027836A2 (no)
BR112013023266A2 (no)
BR112013032392A2 (no)
BR112013025487A2 (no)